Let’s start this one with a question… What do thiazolidinediones, DPP4 inhibitors, acarbose, SGLT2 inhibitors, sulphonylureas, GLP1-agonists, metformin, gliptins, and glitazones all have in common? Yep, they all have stupid names. I remember an old saying – “If there are many ways to treat something it is likely none of them are the best”. The…